Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)

Market Cap	5.35B
Revenue (ttm)	6.90B
Net Income (ttm)	404.63M
Shares Out	107.42M
EPS (ttm)	3.77
PE Ratio	13.21
Forward PE	n/a
Dividend	1.40 (2.81%)
Ex-Dividend Date	Nov 20, 2024

Volume	380,510
Open	49.50
Previous Close	49.20
Day's Range	49.50 - 51.30
52-Week Range	36.20 - 118.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2024

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally. The company offers generic human health products, such as tablet, capsule, powder, cream, ointment, injection, eye and nasal drop, liquid, sachet, and oral solution; and animal health products, including vaccine, bolus, liquid, injection, water soluble powder, and premix. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 4,143
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: NAVANAPHAR

Financial Performance

In 2023, Navana Pharmaceuticals's revenue was 5.71 billion, an increase of 19.91% compared to the previous year's 4.76 billion. Earnings were 356.94 million, an increase of 30.27%.